{"id":"W2809860024","doi":"10.1002/clc.23018","title":"Rationale and design of a randomized study to assess the efficacy and safety of evolocumab in patients with diabetes and dyslipidemia: The BERSON clinical trial","year":2018,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Royal Victoria Hospital","funders":"Amgen","keywords":"Evolocumab; Medicine; Dyslipidemia; PCSK9; Internal medicine; Atorvastatin; Placebo; Hyperlipidemia; Statin; Diabetes mellitus; Type 2 diabetes; Gastroenterology; Familial hypercholesterolemia; Alirocumab; Endocrinology; Cholesterol; Lipoprotein; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.02179907,0.0001243326,0.002031389,0.00003966174,0.00006772153,0.000005301212,0.0000837956,0.0001567061,0.00000278697],"category_scores_gemma":[0.01107144,0.0000560749,0.0001905422,0.0001182843,0.001403551,0.00002192199,0.0001140323,0.0003390534,4.285828e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009755679,"about_ca_system_score_gemma":0.0001320066,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001768944,"about_ca_topic_score_gemma":0.00001128127,"domain_scores_codex":[0.9924581,0.00551837,0.001228006,0.0003580513,0.0002682992,0.0001691669],"domain_scores_gemma":[0.9876133,0.01129835,0.0002577156,0.0004899742,0.0002320398,0.0001086088],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3217902,0.0002855859,0.6700002,0.0000199875,0.0007722614,0.000001209911,0.0002421786,0.000005297696,7.49972e-7,0.0000344816,0.00007127263,0.006776651],"study_design_scores_gemma":[0.3338566,0.008392559,0.6569086,0.00003058821,0.0004829601,0.000001329207,0.000141212,0.00004200139,8.723679e-7,0.00003754003,0.00006316294,0.0000426529],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907553,0.000427804,0.0007145852,0.0005831596,0.0002146106,0.007262077,0.000004886669,0.000004678806,0.00003291862],"genre_scores_gemma":[0.9984627,0.0001273383,0.0003699232,0.0003498832,0.0005599485,0.0001128984,0.000003116987,0.000009430336,0.000004800242],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01309161,"threshold_uncertainty_score":0.9972587,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0840738462412197,"score_gpt":0.3879460096833942,"score_spread":0.3038721634421744,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}